allulose and glp-1 Release by Rare Sugar D-Allulose Ameliorates Sucrose-Induced Obesity Glucose Intolerance in Ovariectomized Mice ALLULOSE-NOT INTERESTED IN TAKING SEMAGLUTIDE-TRY

Learn the hidden risks and how to protect your long-term health.

Their pleiotropic benefits arise from intricate signalling cascades that regulate appetite, insulin secretion, and energy homeostasis across multiple tissues.

To address these gaps, we introduce an evidence-informed nutrition framework to guide health care professionals in assessment, diagnosis, intervention, and monitoring during GLP1 therapy

Ozempic and other GLP-1 receptor agonists can increase insulin secretion, suppress glucagon release, slow digestion, and more

The development of dual GIPRGLP1R coagonists that bind to either one or the other receptor (sequence-mixed dual agonists) has emerged as an innovative therapeutic strategy for obesity and type 2 diabetes